1569: Evaluation of a Novel Drug to Treat Canine Cutaneous Lymphoma

Grant Status: Open

Grant Amount: $37,844
Dr. Douglas H Thamm, VMD, Colorado State University
March 1, 2012 - December 31, 2013
Sponsor(s): American Shih Tzu Club, Inc., Flat-Coated Retriever Foundation, Giant Schnauzer Club of America, Golden Retriever Foundation, Gordon Setter Club of America, National Beagle Club, National Foxhunters Association, Samoyed Club of America Education & Research Foundation
Breed(s): -All Dogs
Research Program Area: Oncology - Lymphoma

Abstract

Canine lymphoma is one of the most common cancers encountered in veterinary oncology. While most canine multicentric lymphoma patients initially respond to currently available chemotherapy protocols, response rates are considerably lower in patients with cutaneous T cell lymphoma (CTCL), and generally brief in duration. In this study, Dr. Thamm will evaluate the effectiveness of a novel anti-cancer drug, GS-9219, in canine CTCL through the completion of a phase-II clinical trial. Successful demonstration of efficacy of GS-9219 against canine CTCL would provide an important drug in the veterinarian's armamentarium against this challenging disease.

Publication(s)

Manuscript in preparation.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $40
  • $60
  • $100
  • $250
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2016 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software